Request Trial
race-1-
OSTILL / SHUTTERSTOCK.COM
3 March 2015AmericasGunars Gaikis

Generics in Canada: The race for market exclusivity

The Supreme Court of Canada has tentatively set April 20, 2015 as the date for the hearing of Sanofi’s appeal against a court’s decision that the company is liable for generic drug maker Apotex’s lost sales of ramipril based on section 8 of the Patented Medicines (Notice of Compliance) Regulations (NOC Regulations).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Jones Day adds in-house biologics specialist to Boston office
20 May 2026   The firm brings in a former VP at a biotech company, with biologics experience across antibodies, antibody drug-conjugates, peptides and gene and cell therapies.
Americas
Kirkland & Ellis subject of alleged conflict in trade secrets clash
19 May 2026   In the firm’s second IP conflict dispute in a year, a healthcare tech company claims Kirkland lawyers "committed the cardinal sin of trying to represent the conflicting interests of opposing parties".
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026   The award could rise to several billions under federal antitrust law, after the pharma company was found to have engaged in anticompetitive conduct over constipation drug Amitiza.


Editor's picks

Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026

Editor's picks

Americas
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
19 May 2026
Americas
From the courtroom: Hikma v Amarin SCOTUS oral arguments
30 April 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026

More features

Jones Day adds in-house biologics specialist to Boston office
Kirkland & Ellis subject of alleged conflict in trade secrets clash
Takeda to appeal $885m jury verdict over ‘pay-for-delay’ scheme
AbbVie’s trade secret suit against a Chinese rival gets green light
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
Blank Rome adds to growing team with patent agent from MBHB
BMS signs $15.2bn deal with China’s top pharma company
Medtech company sues over seven patents for incontinence products